Related Experiment Video
Updated: Aug 15, 2026

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
Published on: March 11, 2014
Cervical adenocarcinoma in situ
M P Hopkins1, J A Roberts, R W Schmidt
1Department of Obstetrics and Gynecology, University of Michigan Medical Center, Ann Arbor.
Abstract:
Cervical adenocarcinoma in situ is a rare disease. Eighteen patients with this disease seen at the University of Michigan Medical Center are reported, with a review of their clinical characteristics and pathologic data. These patients represented 9.2% of all endocervical adenocarcinomas seen during the study period. Their median age was 37 years, compared with a median age of 47 years in those women with invasive disease. Sixty percent presented with abnormal bleeding. Cone biopsy margins were examined in 12 patients, and accurately predicted the presence or absence of disease in ten of 12 hysterectomy specimens. One patient developed recurrent adenocarcinoma, and died of disease 16 years after initial diagnosis. Based on these data, it is suggested that hysterectomy and pelvic lymph node evaluation be used to treat these patients.
Related Concept Videos
In-situ Hybridization
Types of probes and labels
A probe is a complementary strand of DNA or RNA that binds to corresponding nucleotide sequences in a cell. Many...
Cellular Adaptation IV: Dysplasia and Metaplasia

